Tofacitinib is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheuma...

Tofacitinib 5 mg, marketed under the brand name Tofacent, is a medication commonly utilized for its immunomodulatory and anti-inflammatory properties. It belongs to the class of drugs known as Janus kinase (JAK) inhibitors and works by interfering with specific cellular signaling pathways involved i...